Meet The profesors
HomeEditionsAbout MTPAbout usContact
Breast CancerColorectal CancerGISTLung CancerNHL CancerProstate CancerRenal Cell Cancer
You are here: Home: Meet The Professors - Breast Cancer 1 | 2009: Faculty Affiliations and Disclosures

Content Validation and Disclosures

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY Drs Perez and Winer had no real or apparent conflicts of interest to disclose. The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr HudisAdvisory Committee: Genentech BioOncology, Novartis Pharmaceuticals Corporation, Pfizer Inc, Sanofi-Aventis; Consulting Agreement: Amgen Inc; Paid Research: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Onyx Pharmaceuticals Inc. Dr MillerConsulting Agreements: Eli Lilly and Company, Genentech BioOncology, Roche Laboratories Inc; Paid Research: Pfizer Inc, Roche Laboratories Inc; Speakers Bureau: Genentech BioOncology, Roche Laboratories Inc. Dr SwainPaid Travel: Sanofi-Aventis.

COMMUNITY PANEL — Drs Deutsch, Luedke, Steinecker, Tetreault, Towell and Tsarwhas had no real or apparent conflicts of interest to disclose. Dr Astrow Advisory Committee: Ortho Biotech Products LP; Consulting Agreement: Pfizer Inc. Dr De FuscoSpeakers Bureau: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation. Dr NgSpeakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr RobbinsStock Ownership: Celgene Corporation. Dr TracyAdvisory Committee: Genomic Health Inc; Stock Ownership: Amgen Inc, Biogen Idec, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, Millennium Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc.

MODERATORNeil Love: Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME activities from the following commercial interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol- Myers Squibb Company, Celgene Corporation, Cephalon Inc, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, Genzyme Corporation, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Medical Oncologist Community Panel

Alan B Astrow, MD
Director, Division of Medical
Oncology/Hematology
Maimonides Cancer Center
Brooklyn, New York

Patricia A De Fusco, MD
Senior Staff, Department
of Medicine, Hartford Hospital
Hartford, Connecticut

Margaret A Deutsch, MD
Cancer Centers of North Carolina
Raleigh, North Carolina

Susan L Luedke, MD
Medical Oncology, St Louis
Cancer and Breast Institute
St Louis, Missouri

Kenneth K Ng, MD
Associate Attending Physician
Chief, Medical Oncology
Memorial Sloan-Kettering
Cancer Center
Rockville Centre, New York

Mark S Robbins, MD
Sun City Center, Florida

Gary Steinecker, MD
Attending Oncologist
Advocate Christ Hospital
Oak Lawn, Illinois

Scott A Tetreault, MD
Florida Cancer Specialists
Sarasota Division
Sarasota, Florida

Brenda Towell, MD
Texas Oncology
Austin, Texas

Martha A Tracy, MD
Alta Bates Comprehensive
Cancer Center
Chair, Alta Bates Breast
Cancer Program
Northern California Hematology
Oncology Consultants
Berkley, California

Dean G Tsarwhas, MD
Medical Oncologist
North Shore Oncology-
Hematology Associates
Libertyville, Illinois

 

Table of Contents Top of Page